Granules India balance sheet

As of Mar 2026

Total assets: ₹7,720cr+23.5% on Mar 2025
Shareholders' equity: ₹5,085cr+36.9% on Mar 2025
Total debt: ₹1,338cr+4.1% on Mar 2025
Cash and investments: ₹880cr+88.8% on Mar 2025

₹ crore except per share

Tap a line for its trend	FY26Mar 2026	FY25Mar 2025	FY24Mar 2024	FY23Mar 2023	FY22 and earlierAlpha Plus

Current assets
Non-current assets					FY22 and earlierEvery year the company has filed comes with Alpha Plus.
	3,051	2,217	1,856	1,631
	406	437	260	228
	11.7	0.0	0.0	0.0
	187	209	240	280
	3.1	3.2	12.2	11.3
	0.8	22.0	21.5	21.2
	21.9	20.5	16.7	14.8
	22.8	42.6	38.2	36.1
	63.8	67.8	37.1	1.4
	206	160	173	143
	3,952	3,137	2,616	2,330
	1,673	1,343	1,301	1,149
	909	942	986	949
	880	466	381	292
	68.8	130	5.3	21.2
	4.5	1.5	2.9	3.2
	1,863	1,540	1,375	1,264
	232	233	229	160
	3,768	3,115	2,905	2,574
	7,720	6,253	5,521	4,905
Equity
	24.8	24.3	24.2	24.2
	5,060	3,691	3,201	2,811
	5,085	3,716	3,226	2,835
	5,085	3,716	3,226	2,835
Liabilities
	297	312	69.0	149
	161	159	83.2	70.6
	458	471	152	219
	47.8	31.8	37.9	29.3
	37.0	31.4	23.1	7.7
	543	534	213	256
	1,041	974	1,154	910
	673	726	750	782
	279	26.0	135	78.9
	1,993	1,726	2,039	1,771
	54.6	31.7	11.8	14.6
	3.3	18.2	5.6	12.7
	41.6	227	26.1	15.1
	2,092	2,003	2,082	1,814
	2,635	2,537	2,295	2,070
	7,720	6,253	5,521	4,905
Trade payables — MSME split
	12.6	6.4	—	—
	660	720	—	—

Open the chart

From the company's filings with NSE and BSE (Ind-AS), consolidated. For information only, not investment advice.

alphave

GRANULES₹840.45

Granules India Ltd.

· Pharma & Health

₹ CrorePeersAUROPHARMA IPCALAB AARTIDRUGS ERIS INDGN EMCURE JUBLPHARMA CONCORDBIOMcap ₹20,826 Cr

View

In ₹ Crore except Per Share As of	FY23 31/03/2023	FY24 31/03/2024	FY25 31/03/2025	FY26 31/03/2026	Last 12M 30/06/2026
Non-current Assets
+ Property, Plant & Equipment	1,631.4	1,856.1	2,217.4	3,051.4	3,051.4
+ Capital Work-in-Progress	228.0	259.5	436.9	406.5	406.5
+ Goodwill	0.0	0.0	0.0	11.7	11.7
+ Other Intangibles	279.6	239.5	209.0	187.1	187.1
+ Intangibles under Development	11.3	12.2	3.2	3.1	3.1
+ Non-current Investments	21.2	21.5	22.0	0.8	0.8
+ Other Non-current Financial Assets	14.8	16.7	20.5	21.9	21.9
Non-current Financial Assets	36.1	38.2	42.6	22.8	22.8
+ Deferred Tax Assets	1.4	37.1	67.8	63.8	63.8
+ Other Non-current Assets	142.6	173.3	160.0	206.0	206.0
Total Non-current Assets	2,330.4	2,615.9	3,137.1	3,952.3	3,952.3
Current Assets
+ Inventories	1,149.4	1,300.5	1,342.8	1,673.0	1,673.0
+ Trade Receivables	948.5	985.8	942.2	909.4	909.4
+ Cash & Cash Equivalents	291.6	381.1	466.1	880.2	880.2
+ Other Bank Balances	21.2	5.3	130.3	68.8	68.8
+ Other Current Financial Assets	3.2	2.9	1.5	4.5	4.5
Current Financial Assets	1,264.5	1,375.1	1,540.0	1,862.9	1,862.9
+ Other Current Assets	160.2	229.4	232.6	231.7	231.7
Total Current Assets	2,574.1	2,905.0	3,115.5	3,767.6	3,767.6
Total Assets	4,904.6	5,521.0	6,252.6	7,720.0	7,720.0
Equity
+ Equity Share Capital	24.2	24.2	24.3	24.8	24.8
+ Other Equity / Reserves	2,810.7	3,201.3	3,691.3	5,060.2	5,060.2
Equity — Owners of Parent	2,834.9	3,225.5	3,715.6	5,085.0	5,085.0
Total Equity	2,834.9	3,225.5	3,715.6	5,085.0	5,085.0
Liabilities
+ Borrowings — Non-current	148.6	69.0	311.5	297.2	297.2
+ Other Non-current Financial Liab	70.6	83.2	159.2	161.0	161.0
Non-current Financial Liabilities	219.2	152.2	470.7	458.1	458.1
+ Provisions — Non-current	29.3	37.9	31.8	47.8	47.8
+ Deferred Tax Liabilities	7.7	23.1	31.4	37.0	37.0
Non-current Liabilities	256.2	213.1	533.8	542.9	542.9
+ Borrowings — Current	910.0	1,154.3	974.3	1,041.0	1,041.0
+ Trade Payables	782.1	749.5	726.1	672.8	672.8
+ Other Current Financial Liab	78.9	134.9	26.0	278.8	278.8
Current Financial Liabilities	1,771.0	2,038.7	1,726.3	1,992.6	1,992.6
+ Provisions — Current	14.6	11.8	31.7	54.6	54.6
+ Current Tax Liabilities	12.7	5.6	18.2	3.3	3.3
+ Other Current Liabilities	15.1	26.1	226.9	41.6	41.6
Current Liabilities	1,813.5	2,082.3	2,003.2	2,092.0	2,092.0
Total Liabilities	2,069.7	2,295.4	2,537.0	2,635.0	2,635.0
Total Equity & Liabilities	4,904.6	5,521.0	6,252.6	7,720.0	7,720.0
Trade Payables — MSME split
+ Dues to Micro & Small — Current	—	—	6.4	12.6	12.6
+ Dues to Other Creditors — Current	—	—	719.7	660.2	660.2
Other Filed Concepts — mapped but not yet placed in the schedule
Investments	21.2	—	—	—	—

As filed, sign as filed — read the label, not the sign. A line appears only when the company tagged that concept in at least one period shown, so depth follows the filer: pre-Ind-AS, insurance and NBFC blocks stay hidden unless they were actually reported. Alternate tags for the same idea (e.g. two spellings of a deferred-tax element) are kept as separate lines rather than merged, because merging them would be a guess. Ratios, per-share figures and counts render as raw numbers, not ₹ Crore. No consensus estimates → no Est columns. Click any row to chart it.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.